French biotech Overseed raises €6.7 million to become local manufacturer of 100% medical cannabis medicines

Published on July 4, 2024

Within a strict pharmaceutical framework, France is preparing to authorize the use and health insurance coverage of medical cannabis in January 2025. In this context, Orléans-based Overseed Biotech, which specializes in agronomic research and the development of medicines derived from the cannabis plant, has announced a €6.7 million Series A fundraising, following a €2.5 million…

This content is for members only. Visit the site and log in/register to read.

The post French biotech Overseed raises €6.7 million to become local manufacturer of 100% medical cannabis medicines appeared first on EU-Startups.

Continue reading on website
Other news

EU-Startups Podcast | Episode 75: Robert Jackle, Partner at Visionaries Club

July 4, 2024
In this episode, we catch up with Robert Jackle, a Partner at Visionaries Club, a leading European early-stage VC fund with offices in London and Berlin. Visionaries Club’s founders and operators are behind companies such as UiPath, Miro, Flixbus, Mollie, Spotify, Personio, Adyen, HelloFresh, and Pitch, and have only just gone through your journey themselves…. This content is for members only. Vis

London-based Natcap secures €9.2 million to bring nature into business decision-making

July 4, 2024
Natcap announced it has secured €9.2 million in an oversubscribed Series A funding round to scale its pioneering nature tech product. This funding will help accelerate Natcap’s rapid growth supporting organisations to understand their nature-related risks and opportunities.  Natcap has secured new funding from André Hoffmann, Norinchukin Capital, Yeo Ventures, and Pelican Ag. The round… This conte